Guggenheim Capital’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$237K Buy
14,803
+4,309
+41% +$84.9K ﹤0.01% 1510
2026
Q2
$269K Sell
10,494
-63
-0.6% -$1.48K ﹤0.01% 1552
2026
Q1
$158K Sell
10,557
-4,926
-32% -$84K ﹤0.01% 1546
2025
Q4
$225K Sell
15,483
-12,326
-44% -$215K ﹤0.01% 1645
2025
Q3
$499K Buy
27,809
+6,435
+30% +$94.4K ﹤0.01% 1181
2025
Q2
$365K Buy
21,374
+2,180
+11% +$21.8K ﹤0.01% 1326
2025
Q1
$139K Buy
19,194
+2,519
+15% +$28.7K ﹤0.01% 1578
2024
Q4
$234K Buy
+16,675
New +$246K ﹤0.01% 1537

Other funds holding CORZ

Guggenheim Capital's CORZ Position: Q3 2026 in Review

Guggenheim Capital increased its Core Scientific (CORZ) stake by 41% in Q3 2026, buying an estimated $84.9K and bringing the position to 14,803 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Guggenheim Capital first reported a position in CORZ in Q4 2024 and has held it in 8 quarters since. The position peaked at $499K in Q3 2025. 409 funds tracked by Wall St. Rank hold CORZ as of Q3 2026.

  • Guggenheim Capital held 14,803 shares of Core Scientific worth $237K as of Q3 2026.
  • Guggenheim Capital bought 4,309 Core Scientific shares in Q3 2026, an estimated $84.9K.
  • Core Scientific made up ﹤0.01% of Guggenheim Capital's portfolio in Q3 2026, its #1510 holding.
  • Guggenheim Capital first reported a position in Core Scientific in Q4 2024 and has held it in 8 quarters since.
  • Guggenheim Capital's Core Scientific position peaked at $499K in Q3 2025.
  • 409 funds tracked by Wall St. Rank held Core Scientific as of Q3 2026.

Based on Guggenheim Capital's 13F filing for Q3 2026, filed 16 Nov 2026.